The research in the NEJM shows that patients can be encouraged to adhere to their medication and management regimens through a reduction the costs of their medications, despite the investment needed to lower the costs. However, those who already had rich benefits tended to extend their use of health resources, an “unintended consequence.” This may be the fuel for precision-focused value-based designs.
Read the free full-text report from the NEJM.

